Navigation Links
MAP Pharmaceuticals to Present at Upcoming Investor Conferences
Date:5/1/2012

MOUNTAIN VIEW, Calif., May 1, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will participate in the following investor conferences in May 2012:

Deutsche Bank 37th Annual Healthcare Conference
Tuesday, May 8, at 8:40 a.m. ET in Boston

Bank of America Merrill Lynch 2012 Healthcare Conference
Tuesday, May 15, at 3:40 p.m. PT in Las Vegas

A live webcast of each event will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay also will be available within 24 hours for seven days following each presentation.

About MAP Pharmaceuticals

MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the potential acute treatment of migraine. The U.S. Food and Drug Administration reviewed the New Drug Application for LEVADEX and on March 26, 2012, the Company received a Complete Response letter. MAP Pharmaceuticals has entered into a collaboration agreement with Allergan, Inc. to co-promote LEVADEX to neurologists and pain specialists in the U.S. and Canada. The Company also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

CONTACT:
Lisa Borland
MAP Pharmaceuticals, Inc.
650-386-3122
lborland@mappharma.com


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015  Obsidian HDS, the developer of PharmaShine ( ... the management of data on pharmaceutical and device industry ... includes the 2014 Open Payments General and Research data ... 30. The data disclosed on Open Payments for 2014 ... providers totaling $6.49 billion and is the largest public ...
(Date:7/2/2015)... 2015 BGI a annoncé aujourd,hui que ... l,ADN situé à Hong Kong ... of Pathologists  (Collège des pathologistes américains, ou CAP). ... Kong constituent le premier laboratoire clinique ... certification du CAP en Chine, car il satisfait ...
(Date:7/2/2015)... , July 2, 2015 ResMed Inc. (NYSE: ... quarter and fiscal year ended June 30, 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... 31, 2011 Recent information presented at the British ... 2011 indicates a rise in the failure rate of ... was manufactured and marketed by DePuy Orthopaedics, Inc., a ... has released a summary of the results of the ...
... (OTC BB: ONCS), a developer of innovative medical approaches to ... more than $1 million of new capital through the issuance ... at a price of $0.75 per unit for gross proceeds ... stock and one share purchase warrant entitling the warrant holder ...
Cached Medicine Technology:Failure Rate of DePuy ASR XL Hip Implant Rising 2OncoSec Medical Closes $1.1M Financing 2
(Date:7/3/2015)... ... 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... reveal biblical truth and expose popular lies regarding proper relationships according to the bible. ... immediately goes into the core of the subject by explaining why certain types of ...
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Albany, Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium ... growing companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Following the ... stated the number of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared ... biggest threats to American society right now," Becic said. "We must understand the magnitude ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... the market. , According to the U.S. Department of Energy, it’s very important to ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... sprinting ahead in a race against the clock to deliver ... virus before cooler weather ushers in the 2009-2010 flu season. ... Chemical & Engineering News , ACS, weekly newsmagazine, focuses on ... infections. C&EN senior correspondent Ann Thayer cites World Health ...
... of electronic medical records holds the key, study finds ... be possible to use a person,s electronic medical ... before it actually occurs, according to U.S. researchers. ... 500,000 adults that included at least four years of ...
... ... challenges and key steps to help organizations take a top-down approach to reduce audit ... ... Policy Compliance Group, an organization spends 30-50 percent more on compliance and IT risk ...
... DSS Research announces their Senior Health Risk Assessment (SrHRA). ... a single scoring system. It uses a variety of ... and current health care usage, into an integrated survey ... to high risk on a number of dimensions including ...
... WILMINGTON, Delaware, September 30 According to a new,market ... the global market for,neurostimulation products is expected to be ... billion by 2014, driven by the multiple treatment,applications of ... industry. , Browse 48 market ...
... PHOENIX, Sept. 30 An amazing ... games in support of Breast Cancer Awareness. , (Photo: ... Free Pink Pair Giveaway, Anquan Boldin heard about ... cause. , "For me, it,s important because everyone out ...
Cached Medicine News:Health News:Doctors May Be Able to Predict Domestic Abuse 2Health News:Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 2Health News:Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 3Health News:DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM) 2Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 2Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 3Health News:Football Pros in October Pink Gloves 2
Surgical-grade stainless steel disposable concentric needle with Trocar tip has an insulated platinum-alloy core and two attached 61-cm (24-in) lead wires. Needles sold in packages of 20....
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... delivers excellent sensitivity and specificity for the diagnosis ... test that provides an answer in 6 minutes. ... provide improved patient care with a test that ... out what value we bring to your daily ...
... are made of PTFE coated stainless ... tip, which ensures low friction at ... turn, provides significantly improved patient comfort. ... design for easy and secure grip. ...
Medicine Products: